Clinical Trial Update: A Dose Finding Study of IBI3016 in Mild to Moderate Hypertensive Patients [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial of IBI3016 for mild to moderate hypertension; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• IBI3016

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Hypertension | Phase 2 | Status: NOT_YET_RECRUITING